📰 ET Stocks 🟢 BULLISH 🕒 10 Sep 2026, 08:09 AM IST

Dividend alert! Last day to buy IREDA, Kalyan Jewellers among more than 100 stocks for dividends. Do you own any?

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Dividend alert! Last day to buy IREDA, Kalyan Jewellers among more than 100 stocks for dividends. Do you own any?

📊

Market & Financial Impact: Under Sebi's T+1 settlement cycle, investors need to purchase a company's shares at least one trading day before the record date to ensure the shares are credited to their demat accounts in time, and they become eligible for the corporate action. Accordingly, today is the last opportunity for investors to buy the shares so that they are credited to their accounts by the record date (September 11), making them eligible for the dividend.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Bigger or Better: One order from Power Grid Corp added $1 billion to the market cap of a company – Final part

Banks have received a flood of money. Now comes the real test

New aircraft order opens door for ATR assembly line in India

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

Dividend alert! Last day to buy IREDA, Kalyan Jewellers among more than 100 stocks for dividends. Do you own any?

🔥 More Live Market Stories

The 10-year Treasury yield is approaching 5%. What it means for income-seeking investors

Would you buy stock in a company whose own scientists think the product might kill you?

S&P Global cuts KinderCare rating outlook on enrollment woes

Vertex at cantor healthcare conference: diversification and pipeline push

Arvinas at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline takes center stage

Eikon Therapeutics at Cantor conference: selective cancer drugs advance